Lung Diseases

Researchers find new treatment to reverse COPD and other lung diseases

In a study conducted on mice, researchers found a receptor that could reverse inflammatory responses and combat chronic obstructive pulmonary disease (COPD) and other lung diseases.

Lung X-Ray
Lung X-Ray
Source: Shutterstock: sfam_photo

The findings, published in The FASEB Journal, found that the helpful receptor is one characterized for advanced glycan end-products (RAGE)-specific antagonist chemical compound, FPS-ZM1.

"RAGE disturbances in pulmonary disorders are precise and effective strategies with beneficial clinical effects," said Se-Ran Yang, PhD, an author on the study and an associate professor at the Department of Thoracic and Cardiovascular Surgery in the School of Medicine at Kangwon National University in Gangwon, Korea. "Blockade of RAGE as a novel clinical therapeutic for COPD ameliorates emphysema/COPD development and progression."

The researchers investigated the efficacy of the receptor in both vivo and in vitro COPD models to see what the molecular mechanism by which RAGE influences COPD.

They found that RAGE was association with the up-regulation of DAMP-related signaling pathways. FPS-ZM1 also reversed emphysematous lung symptoms in the mice by a significant margin.

"No one expected the pathogenic roots of COPD to be simple, and this study gives us an indication of the complexity involved.," said Thoru Pederson, PhD, editor-in-chief of  The FASEB Journal. "The current pharmacological armamentarium is limited, and studies like this are thus extremely valuable as a foundation."

Source: Radiology Business

21.02.2017

Read all latest stories

Related articles

Chronic obstructive pulmonary disease

COPD: Biomarker for kidney disease has unexpected benefits

A commonly used biomarker of kidney disease may also indicate lung problems, particularly COPD, or chronic obstructive pulmonary disease, according to new research published online in the American…

Therapy

New way to predict COPD progression

New research has found that a process initiated in white blood cells known as neutrophils may lead to worse outcomes for some patients with chronic obstructive pulmonary disease (COPD). The discovery…

Medical nanoparticles

Local treatment of lung cancer

Nanoparticles are extremely small particles that can be modified for a variety of uses in the medical field. For example, nanoparticles can be engineered to be able to transport medicines…

Related products

Research use only (RUO)

Eppendorf - Mastercycler nexus X2

Eppendorf AG

Research use only (RUO)

SARSTEDT - Low DNA Binding Micro Tubes

SARSTEDT AG & CO. KG

Research use only (RUO)

Shimadzu - CLAM-2000

Shimadzu Europa GmbH